Rheopheresis: rheologic, functional, and structural aspects.
about
Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial.Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss.Multicenter prospective, randomized, double-masked, placebo-controlled study of Rheopheresis to treat nonexudative age-related macular degeneration: interim analysis.Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy peopleLong-term outcomes of rheohaemapheresis in the treatment of dry form of age-related macular degeneration.Dynamics of blood count after rheohemapheresis in age-related macular degeneration: possible association with clinical changes.A critical review on the use of lipid apheresis and rheopheresis for treatment of peripheral arterial disease and the diabetic foot syndrome.The selective therapeutic apheresis procedures.Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation in the peripheral venous blood: a model in hypercholesterolaemic patients.Comparative analysis between dextran sulfate adsorption and direct adsorption of lipoproteins in their capability to reduce erythrocyte adhesiveness/aggregation in the peripheral blood.Double filtration plasmapheresis in different diseases in Thailand.Acute effect of rheopheresis on peripheral endothelial dysfunction in patients suffering from sudden hearing loss.eNOS gene affects red cell deformability: role of T-786C, G894T, and 4a/4b polymorphisms.Seeing is believing: A review of apheresis therapy in the treatment of ophthalmologic disease.Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies.LDL-apheresis: technical and clinical aspects.Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form
P2860
Q31151097-2AC22B5F-7762-446B-8431-273C3E193427Q32178393-C352E3B6-9C7B-49EE-BE06-22ABFD311F4BQ34330883-9131825D-E9F7-4E25-A4FE-97A78EA6372DQ35582098-97334D0A-1E14-429D-BD9A-286AF1064A83Q37433013-A2B87198-602E-4EA0-A0D2-42F6A70E63CFQ37664653-8207947F-3CA4-4108-8D4F-A2CD168D714BQ37969137-BC984787-1D66-409A-95F5-C5C519C3E1F1Q38082734-B15BC519-0BE7-422F-B72C-2FFA1187FC53Q44667848-09635E42-927A-45B9-B282-40B42A825D3EQ44884396-136E318D-EBAE-4922-8E75-B082EA0BB9F9Q45781215-9CD1B654-C3F2-43E3-AB1D-A2F24DD381FFQ46733527-6F36C39C-4F01-418B-BCEB-B4799FFBB435Q46770308-A1984043-B8C8-4BDE-97A2-0C52CE5C585DQ48278612-9224965D-A046-48D2-9681-A7642819E9F8Q50571564-A36C035F-7A26-46EB-8B14-9F22C36DC2F7Q50753112-435DA5DA-A341-442A-B330-50249DA8BB42Q55652029-D6F15A84-B828-4377-9ABA-ACF45CA3F920Q58860417-ED9C116C-5A36-4E51-A8D4-3CF759DD99E1
P2860
Rheopheresis: rheologic, functional, and structural aspects.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Rheopheresis: rheologic, functional, and structural aspects.
@ast
Rheopheresis: rheologic, functional, and structural aspects.
@en
Rheopheresis: rheologic, functional, and structural aspects.
@nl
type
label
Rheopheresis: rheologic, functional, and structural aspects.
@ast
Rheopheresis: rheologic, functional, and structural aspects.
@en
Rheopheresis: rheologic, functional, and structural aspects.
@nl
prefLabel
Rheopheresis: rheologic, functional, and structural aspects.
@ast
Rheopheresis: rheologic, functional, and structural aspects.
@en
Rheopheresis: rheologic, functional, and structural aspects.
@nl
P2093
P2860
P1476
Rheopheresis: rheologic, functional, and structural aspects.
@en
P2093
Berrouschot J
Erdtracht B
Fassbender C
Fassbender T
P2860
P304
P356
10.1046/J.1526-0968.2000.004005348.X
P577
2000-10-01T00:00:00Z